HHS · Insider Trading
Harte-Hanks, Inc. Common Stock
Every open-market purchase and sale reported by HHS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | David Scott Fisher | President | MIXED | −7,876 | −$20.64K |
| 2025-12-15 | Genevieve Claire Combes | Director | A | +27,861 | +$89.99K |
| 2025-12-11 | Bradley Louis Radoff | Director | A | +27,861 | +$89.99K |
| 2025-07-03 | Robert T. Wyman | General Counsel | A | +25,000 | +$113.75K |
| 2025-07-03 | David A Garrison | Chief Financial Officer | A | +25,000 | +$113.75K |
| 2025-05-30 | Gary Stephen Rosenbach | 10%+ Owner | Buy | +8,400 | +$44.99K |
| 2025-05-28 | Bradley Louis Radoff | Director | J | — | — |
| 2025-05-27 | John H Griffin Jr | Director | J | — | — |
| 2025-05-27 | Elizabeth Ross | Director | J | — | — |
| 2025-05-27 | Robert T. Wyman | General Counsel | MIXED | −853 | −$4.05K |
| 2025-03-05 | Robert T. Wyman | General Counsel | MIXED | −1,777 | −$8.90K |
| 2024-12-06 | Bradley Louis Radoff | Director | Buy | +17,225 | +$100.39K |
| 2024-12-05 | Bradley Louis Radoff | Director | Buy | +42,775 | +$241.55K |
| 2024-11-25 | David A Garrison | Chief Financial Officer | Buy | +850 | +$4.93K |
| 2024-11-18 | David A Garrison | Chief Financial Officer | Buy | +3,904 | +$25.64K |
| 2024-08-19 | John H Griffin Jr | Director | J | — | — |
| 2024-08-19 | Bradley Louis Radoff | Director | J | — | — |
| 2024-08-15 | Bradley Louis Radoff | Director | Buy | +73,900 | +$533.86K |
| 2024-08-12 | Kirk A Davis | Chief Executive Officer | Buy | +7,143 | +$50.00K |
| 2024-08-12 | David A Garrison | Chief Financial Officer | Buy | +4,250 | +$29.89K |
| 2024-08-07 | Robert T. Wyman | General Counsel | MIXED | −1,624 | −$12.86K |
| 2024-05-31 | Elizabeth Ross | Director | A | +12,048 | +$90.00K |
| 2024-05-31 | John H Griffin Jr | Director | A | +12,048 | +$90.00K |
| 2024-05-31 | Bradley Louis Radoff | Director | A | +12,048 | +$90.00K |
| 2024-05-31 | Genevieve Claire Combes | Director | A | +12,048 | +$90.00K |
| 2024-05-29 | Robert T. Wyman | General Counsel | MIXED | −834 | −$6.16K |
| 2024-05-17 | Bradley Louis Radoff | Director | — | — | — |
| 2024-05-15 | Bradley Louis Radoff | Director | Buy | +25,000 | +$179.71K |
| 2024-05-13 | David A Garrison | Chief Financial Officer | Buy | +4,125 | +$29.70K |
| 2024-05-13 | Kirk A Davis | Chief Executive Officer | Buy | +7,050 | +$50.00K |
| 2024-03-04 | Robert T. Wyman | General Counsel | A | +12,500 | +$96.75K |
| 2024-02-01 | David A Garrison | Chief Financial Officer | A | +64,600 deriv. | — |
| 2023-12-05 | Bradley Louis Radoff | Director | Buy | +20,000 | +$144.67K |
| 2023-12-04 | Bradley Louis Radoff | Director | Buy | +20,000 | +$144.67K |
| 2023-11-29 | Bradley Louis Radoff | Director | Buy | +10,000 | +$68.20K |
| 2023-11-16 | Kirk A Davis | Chief Executive Officer | Buy | +5,739 | +$40.55K |
| 2023-08-21 | David L Copeland | Director | A | +16,216 | +$90.00K |
| 2023-08-21 | Genevieve Claire Combes | Director | A | +16,216 | +$90.00K |
| 2023-08-21 | Bradley Louis Radoff | Director | A | +16,216 | +$90.00K |
| 2023-08-21 | John H Griffin Jr | Director | A | +16,216 | +$90.00K |
| 2023-08-18 | John H Griffin Jr | Director | Buy | +771 | +$4.35K |
| 2023-08-18 | John H Griffin Jr | Director | Buy | +8,129 | +$45.70K |
| 2023-08-16 | Kirk A Davis | Chief Executive Officer | Buy | +9,542 | +$50.95K |
| 2023-08-15 | Kirk A Davis | Chief Executive Officer | A | +240,000 deriv. | — |
| 2023-08-08 | Laurilee Kearnes | Chief Financial Officer | F | −11,150 | −$65.34K |
| 2023-08-08 | Robert T. Wyman | General Counsel | F | −3,608 | −$21.14K |
| 2023-05-26 | Laurilee Kearnes | Chief Financial Officer | F | −989 | −$5.70K |
| 2023-05-26 | Brian Linscott | Chief Executive Officer | F | −1,633 | −$9.41K |
| 2023-05-26 | Robert T. Wyman | General Counsel | F | −593 | −$3.42K |
| 2023-05-24 | Brian Linscott | Chief Executive Officer | Buy | +5,000 | +$27.86K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Gary Stephen Rosenbach | 10%+ Owner | 761,733 | $2.99M |
| John H Griffin Jr | Director | 209,820 | $824.59K |
| David Scott Fisher | President | 72,124 | $283.45K |
| Genevieve Claire Combes | Director | 42,499 | $167.02K |
| Bradley Louis Radoff | Director | 39,909 | $156.84K |
| Robert T. Wyman | General Counsel | 35,551 | $139.72K |
| David A Garrison | Chief Financial Officer | 25,000 | $98.25K |
| Elizabeth Ross | Director | 12,048 | $47.35K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HHS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.